Πέμπτη 27 Αυγούστου 2020

 


Brachytherapy Care during the COVID-19 Pandemic: Practice Statement from a Cancer Center in Wuhan, China
Publication date: Available online 26 August 2020Source: BrachytherapyAuthor(s): Yao Jiang, Guiling Li, Biyuan Xing, Ye Wang, Zhao Liu, Yingchao Zhao
Brachytherapy
Thu Aug 27, 2020 14:04
Comparison of Continuous Infusion of Epinephrine and Phenylephrine on Hemodynamics During Spinal Anesthesia for Cesarean Delivery: A Randomized Controlled Trial
Publication date: Available online 26 August 2020Source: Clinical TherapeuticsAuthor(s): Y.B. Wang, Z.Y. Yang, W.P. Zhang
Clinical Therapeutics
Thu Aug 27, 2020 15:02
Novel [l,2,4]triazolo[3,4- a ]isoquinoline chalcones as new chemotherapeutic agents: Block IAP tyrosine kinase domain and induce both intrinsic and extrinsic pathways of apoptosis
Summary Two novel chemotherapeutic chalcones were synthesized and their structures were confirmed by different spectral tools. Theoretical studies such as molecular modeling were done to detect the mechanism of action of these compounds. In vitro cytotoxicity showed a strong effect against all tested cell lines (MCF7, A459, HepG2, and HCT116), and low toxic effect against normal human melanocytes (HFB4). The lung carcinoma cell line was chosen for further molecular studies. Real-time...
Latest Results for Investigational New Drugs
03:00
Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report
Summary Purpose The CKD4/6 inhibitor abemaciclib is related to adverse events such as hematological toxicity and increase in serum creatinine levels associated with abemaciclib pharmacokinetics. Increase in serum creatinine levels is considered a result of competition with abemaciclib via organic cation transporter 2 and multidrug and toxic compound extrusion. Therefore, we evaluated the association among serum creatinine levels, serum abemaciclib concentrations, and adverse events...
Latest Results for Investigational New Drugs
Thu Aug 27, 2020 03:00
Oxidising agents and its effect on human dentine fluorescence diagnostic measurements
Publication date: September 2020Source: Photodiagnosis and Photodynamic Therapy, Volume 31Author(s): Jonathan Hong-Man Sin, Stephen Hamlet, Laurence J. Walsh, Robert M. Love, Roy George
ScienceDirect Publication: Photodiagnosis and Photodynamic Therapy
Thu Aug 27, 2020 17:10
The effect of laser-activated bleaching with 445 nm and 915 nm diode lasers on enamel micro-hardness; an in vitro study
Publication date: September 2020Source: Photodiagnosis and Photodynamic Therapy, Volume 31Author(s): Sogol Saberi, Mahboubeh Rouzsaz, Farhad Shafie, Sadra Einizadeh, Mohammad Javad Kharazifard, Sima Shahabi
ScienceDirect Publication: Photodiagnosis and Photodynamic Therapy
Thu Aug 27, 2020 17:10

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου